Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/03/040908
CTRI/2022/03/040908
Not yet recruiting
未知

A Retrospective, Observational, Multicentre study on Outcomes of COVID-19 pneumonia in patients with underlying fatty liver

MAX Smart Super specialty Hospital A unit of Gujarmal Modi Hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
MAX Smart Super specialty Hospital A unit of Gujarmal Modi Hospital
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
MAX Smart Super specialty Hospital A unit of Gujarmal Modi Hospital

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients who are positive for SARS CoV\-2 nasopharyngeal swab RT\-PCR
  • •2\. Patients with no history of underlying liver cirrhosis, fatty liver
  • •3\. Patients with no history of underlying liver cancer
  • •4\. Patients with no cardiac ailment
  • •5\. Patients with a CT severity score of \> 1
  • •6\. Availability of upper abdominal cuts on the HRCT chest

Exclusion Criteria

  • •1\. Patients how are negative for SARS CoV\-2 nasopharyngeal swab RT\-PCR
  • •2\. Patients with known history of underlying cirrhosis.
  • •3\. Patients with known history of underlying liver cancer
  • •4\. Patients with CHF
  • •5\. Patients with a CT severity score of \< 1
  • •6\. Non\-availability of upper abdominal cuts on the HRCT chest

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A multi-center retrospective observational study of effectiveness, safety and treatment status of tirabrutinib in relapsed or refractory pcnsl (ROSETTA)Relapsed or refractory Primary CNS LymphomaPrimary CNS lymphomaD008228
JPRN-jRCT1021230006agane Motoo206
Completed
Not Applicable
A multicenter retrospective observational study evaluating the safety and efficacy of immune checkpoint inhibitors in patients with advanced or recurrent lung cancer after COVID-19 vaccination (NEJ061)advanced or recurrent lung cancer
JPRN-UMIN000048096Specified Nonprofit Corporation North East Japan Study Group850
Recruiting
Not Applicable
The study on prognosis in patients with fatty liver
JPRN-UMIN000046497Yokohama City University3,000
Completed
Phase 4
This is an observational study in patients to Profile Chronic Cholestatic Liver Diseases who are prescribed Udiliv for their treatmentHealth Condition 1: null- Chronic Cholestasis Liver Disease
CTRI/2014/05/004615Abbott India Limited250
Completed
Not Applicable
An observational multicenter study comparing Tenecteplase assisted Percutaneous Coronary Intervention (PCI) versus primary PCI in Indian patients with ST elevation Myocardial InfarctioHealth Condition 1: null- Patients with acute STEMI who are to be treated with primary PCI/pharmacoinvasive therapy within 12 hours of symptoms onset will be included.
CTRI/2011/08/001950STEMI India Charitable Trust200